Below are some of the key findings from this pancreatic cancer therapeutics market analysis report
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
Get a FREE sample now!
Global pancreatic cancer therapeutics industry outlook
The rising prevalence of pancreatic cancer in developed countries due to the lack of therapeutic approaches for early-stage detection is driving the pancreatic cancer therapeutics market. The high incidence of pancreatic cancer leads to germline mutations which cause the defective genes to pass from parents to children, making the early detection of pancreatic cancer important, leading to the growth of the pancreatic cancer therapeutics market.
The increasing demand for targeted therapy is another factor driving the growth of the pancreatic cancer therapeutics market. Targeted therapy singles out specific receptors that are present in the cancer cells and does not harm the peripheral healthy cells of the body unlike the traditional therapeutics method like chemotherapy. The rising prevalence of pancreatic cancer coupled with increasing demand for targeted therapy is driving the pancreatic cancer therapeutics market growth at a CAGR of more than 8% during the forecast period.
Top pancreatic cancer therapeutics companies covered in this market research report
The global pancreatic cancer therapeutics market is extremely concentrated. The market is in the growth phase, and the competition is expected to become intense by the end of the forecast period. To help clients improve their revenue shares in the market, this research report provides an analysis of the market’s competitive landscape and offers information on the products offered by various leading companies. Additionally, this pancreatic cancer therapeutics market analysis report suggests strategies companies can follow and recommends key areas they should focus on, to make the most of upcoming growth opportunities.
The report offers a detailed analysis of several leading companies, including:
- Eli Lilly
- F. Hoffmann-La Roche
- Novartis
- Pfizer
- Shire
Pancreatic cancer therapeutics market segmentation based on products
- Targeted therapy
- Chemotherapy
Targeted therapy was dominating the global pancreatic cancer therapeutics market in 2018. The market share of this segment will increase, and it will continue to dominate the market throughout the next five years.
Pancreatic cancer therapeutics market segmentation based on region
The Americas accounted for the largest pancreatic cancer therapeutics market share in 2018. This region will witness an increase in its market share and remain the market leader for the next five years.
Key highlights of the global pancreatic cancer therapeutics market for the forecast years 2019-2023:
- CAGR of the market during the forecast period 2019-2023
- Detailed information on factors that will accelerate the growth of the pancreatic cancer therapeutics market during the next five years
- Precise estimation of the global pancreatic cancer therapeutics market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the pancreatic cancer therapeutics industry across the Americas, APAC, and EMEA
- A thorough analysis of the market’s competitive landscape and detailed information on several vendors
- Comprehensive details on factors that will challenge the growth of pancreatic cancer therapeutics companies
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
- 2.1 Preface
- 2.2 Preface
- 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
- Market ecosystem
- Market characteristics
- Market segmentation analysis
PART 04: PIPELINE ANALYSIS
PART 05: MARKET SIZING
- Market definition
- Market sizing 2018
- Market size and forecast 2018-2023
PART 06: FIVE FORCES ANALYSIS
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
PART 07: MARKET SEGMENTATION BY PRODUCT
- Market segmentation by product
- Comparison by product
- Targeted therapy - Market size and forecast 2018-2023
- Chemotherapy - Market size and forecast 2018-2023
- Market opportunity by product
PART 08: CUSTOMER LANDSCAPE
PART 09: MARKET SEGMENTATION BY TYPE
- Exocrine pancreatic cancer
- Endocrine pancreatic cancer
PART 10: GEOGRAPHIC LANDSCAPE
- Geographic segmentation
- Geographic comparison
- Americas - Market size and forecast 2018-2023
- EMEA - Market size and forecast 2018-2023
- APAC - Market size and forecast 2018-2023
- Key leading countries
- Market opportunity
PART 11: DRIVERS AND CHALLENGES
- Market drivers
- Market challenges
PART 12: MARKET TRENDS
PART 13: VENDOR LANDSCAPE
- Overview
- Landscape disruption
PART 14: VENDOR ANALYSIS
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Eli Lilly
- F. Hoffmann-La Roche
- Novartis
- Pfizer
- Shire
PART 15: APPENDIX
- Research methodology
- List of abbreviations